JOURNAL ARTICLE

Disease‐Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy.

  • Published In: Annals of Neurology, 2024, v. 95, n. 2. P. 230 1 of 3

  • Database: Academic Search Ultimate 2 of 3

  • Authored By: Ueda, Mitsuharu; Misumi, Yohei; Nomura, Toshiya; Tasaki, Masayoshi; Yamakawa, Shiori; Obayashi, Konen; Yamashita, Taro; Ando, Yukio 3 of 3

Abstract

Hereditary transthyretin (ATTRv) amyloidosis is a rare, fatal systemic disease, associated with polyneuropathy and cardiomyopathy, that is caused by mutant transthyretin (TTR). In addition to liver transplantation, several groundbreaking disease‐modifying drugs (DMDs) such as tetrameric TTR stabilizers and TTR gene‐silencing therapies have been developed for ATTRv amyloid polyneuropathy. They were based on a working hypothesis of the mechanisms of ATTRv amyloid formation. In this retrospective cohort study, we investigated survival of all 201 consecutive patients with ATTRv amyloidosis in our center. The effects of DMDs on survival improvements were significant not only in early‐onset patients but also in late‐onset patients. ANN NEUROL 2024;95:230–236 [ABSTRACT FROM AUTHOR]

Additional Information

  • Source:Annals of Neurology. 2024/02, Vol. 95, Issue 2, p230
  • Document Type:Article
  • Subject Area:Health and Medicine
  • Publication Date:2024
  • ISSN:0364-5134
  • DOI:10.1002/ana.26845
  • Accession Number:175054870
  • Copyright Statement:Copyright of Annals of Neurology is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Looking to go deeper into this topic? Look for more articles on EBSCOhost.